Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG

Bispecific antibodies enable unique therapeutic approaches but it remains a challenge to produce them at the industrial scale, and the modifications introduced to achieve bispecificity often have an impact on stability and risk of immunogenicity. Here we describe a fully human bispecific IgG devoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Nicolas, Elson, Greg, Magistrelli, Giovanni, Dheilly, Elie, Fouque, Nicolas, Laurendon, Amélie, Gueneau, Franck, Ravn, Ulla, Depoisier, Jean-François, Moine, Valery, Raimondi, Sylvain, Malinge, Pauline, Di Grazia, Laura, Rousseau, François, Poitevin, Yves, Calloud, Sébastien, Cayatte, Pierre-Alexis, Alcoz, Mathias, Pontini, Guillemette, Fagète, Séverine, Broyer, Lucile, Corbier, Marie, Schrag, Delphine, Didelot, Gérard, Bosson, Nicolas, Costes, Nessie, Cons, Laura, Buatois, Vanessa, Johnson, Zoe, Ferlin, Walter, Masternak, Krzysztof, Kosco-Vilbois, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339886/
https://www.ncbi.nlm.nih.gov/pubmed/25672245
http://dx.doi.org/10.1038/ncomms7113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339886/
https://www.ncbi.nlm.nih.gov/pubmed/25672245
http://dx.doi.org/10.1038/ncomms7113

Ejemplares similares